REPORT ID 3103

Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Report 2017

Publish Date
12-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acute Respiratory Distress Syndrome Therapeutics for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics market competition by top manufacturers/players, with Acute Respiratory Distress Syndrome Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Therabron Therapeutics, Inc.
    Serendex Pharmaceuticals A/S
    Silence Therapeutics Plc
    Histocell S.L.
    Altor BioScience Corporation
    Athersys, Inc.
    Faron Pharmaceuticals Oy
    FirstString Research, Inc.
    GlaxoSmithKline Plc
    Phylogica Limited

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Methylprednisolone
    Hydrocortisone
    Calf Pulmonary Surfactant for Injection
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    In-Patient
    Out-Patient

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Report 2017
1 Acute Respiratory Distress Syndrome Therapeutics Overview
    1.1 Product Overview and Scope of Acute Respiratory Distress Syndrome Therapeutics
    1.2 Classification of Acute Respiratory Distress Syndrome Therapeutics by Product Category
        1.2.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Methylprednisolone
        1.2.4 Hydrocortisone
        1.2.5 Calf Pulmonary Surfactant for Injection
        1.2.6 Others
    1.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market by Application/End Users
        1.3.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 In-Patient
        1.3.3 Out-Patient
    1.4 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market by Region
        1.4.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Acute Respiratory Distress Syndrome Therapeutics (2012-2022)
        1.5.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics (Volume and Value) by Type
        2.2.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics (Volume) by Application
    2.4 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics (Volume and Value) by Region
        2.4.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Region (2012-2017)

3 China Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    3.1 China Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        3.1.1 China Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        3.1.3 China Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    3.2 China Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    3.3 China Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

4 Japan Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    4.1 Japan Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        4.1.1 Japan Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    4.2 Japan Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    4.3 Japan Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

5 South Korea Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    5.1 South Korea Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        5.1.1 South Korea Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    5.2 South Korea Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    5.3 South Korea Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

6 Taiwan Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    6.1 Taiwan Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        6.1.1 Taiwan Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    6.2 Taiwan Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    6.3 Taiwan Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

7 India Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    7.1 India Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        7.1.1 India Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        7.1.3 India Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    7.2 India Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    7.3 India Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

8 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    8.1 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        8.1.1 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    8.2 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    8.3 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

9 Australia Acute Respiratory Distress Syndrome Therapeutics (Volume, Value and Sales Price)
    9.1 Australia Acute Respiratory Distress Syndrome Therapeutics Sales and Value (2012-2017)
        9.1.1 Australia Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Acute Respiratory Distress Syndrome Therapeutics Sales Price Trend (2012-2017)
    9.2 Australia Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Type
    9.3 Australia Acute Respiratory Distress Syndrome Therapeutics Sales Volume and Market Share by Application

10 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Players/Suppliers Profiles and Sales Data
    10.1 Therabron Therapeutics, Inc.
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Serendex Pharmaceuticals A/S
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Silence Therapeutics Plc
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Histocell S.L.
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Altor BioScience Corporation
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Athersys, Inc.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Faron Pharmaceuticals Oy
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 FirstString Research, Inc.
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 GlaxoSmithKline Plc
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Phylogica Limited
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 Acute Respiratory Distress Syndrome Therapeutics Manufacturing Cost Analysis
    11.1 Acute Respiratory Distress Syndrome Therapeutics Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Acute Respiratory Distress Syndrome Therapeutics Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2017-2022)
    15.1 Asia-Pacific Acute Respiratory